Clinical trial

Liraglutide in Type 1 Diabetes

NCT01722240

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2012-11-01

PhasePHASE3

Study timeline

Study start (actual)2012-11-01Date precision: day

Registry last updated2024-01-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 1 Diabetesunresolved

Interventions

Liraglutide 1.8mgDRUG

PlaceboDRUG

Sponsors & collaborators

University at Buffalolead sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)collaborator

Mapped research locations

BuffaloNew York, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01722240 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.